C4 Therapeutics press release ( CCCC ): Q1 GAAP EPS of -$0.20 beats by $0.06 . Revenue of $6.15M (-15.1% Y/Y) beats by $1.73M . Cash, cash equivalents and marketable securities as of March 31, 2026 were $268.3 million, compared to $297.1 million as of December 31, 2025. The decrease in cash, cash equivalents and marketable securities during the first quarter of 2026 was primarily the result of the...
C4 Therapeutics press release ( CCCC ): Q1 GAAP EPS of -$0.20 beats by $0.06 . Revenue of $6.15M (-15.1% Y/Y) beats by $1.73M . Cash, cash equivalents and marketable securities as of March 31, 2026 were $268.3 million, compared to $297.1 million as of December 31, 2025. The decrease in cash, cash equivalents and marketable securities during the first quarter of 2026 was primarily the result of the cash used to fund operations and advance our programs. The company expects that its current cash, cash equivalents and marketable securities will fund its operations to the end of 2028. More on C4 Therapeutics C4 Therapeutics, Inc. (CCCC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript C4 Therapeutics: Cemsidomide Progress Keeps The Long-Term Thesis Intact C4 Therapeutics, Inc. (CCCC) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow C4 Therapeutics inks new deal with Roche for degrader-antibody conjugates Seeking Alpha’s Quant Rating on C4 Therapeutics
Tenax Therapeutics press release ( TENX ): Q1 GAAP EPS of -$0.35 beats by $0.05 . Tenax Therapeutics reported cash and cash equivalents of $118.8 million as of March 31, 2026. The proceeds from exercises of previously issued warrants during the quarter have enabled Tenax to extend its cash runway, and the Company now expects cash and cash equivalents to fund it through at least the first quarter o...
Tenax Therapeutics press release ( TENX ): Q1 GAAP EPS of -$0.35 beats by $0.05 . Tenax Therapeutics reported cash and cash equivalents of $118.8 million as of March 31, 2026. The proceeds from exercises of previously issued warrants during the quarter have enabled Tenax to extend its cash runway, and the Company now expects cash and cash equivalents to fund it through at least the first quarter of 2028. More on Tenax Therapeutics Tenax Therapeutics: A Binary Bet With Heavy Downside Likely Tenax Therapeutics: Some Future Potential Tenax Therapeutics appoints Thomas Staab as chief financial officer Tenax wins bullish view at Cantor ahead of pivotal readout Seeking Alpha’s Quant Rating on Tenax Therapeutics
If your equity sleeve has more than two or three funds, Vanguard Total Stock Market Index Fund Admiral Shares (NASDAQ:VTSAX) is the case for simplifying. VTSAX owns essentially the entire investable U.S. stock market in one wrapper, charges almost nothing, and has compounded at a rate that has embarrassed most actively managed funds over the ... VTSAX Returns 300% in a Decade While Most Managed Fu...
If your equity sleeve has more than two or three funds, Vanguard Total Stock Market Index Fund Admiral Shares (NASDAQ:VTSAX) is the case for simplifying. VTSAX owns essentially the entire investable U.S. stock market in one wrapper, charges almost nothing, and has compounded at a rate that has embarrassed most actively managed funds over the ... VTSAX Returns 300% in a Decade While Most Managed Funds Fall Behind
Good morning . Oil keeps rising while tech stocks take a pause. UK Prime Minister Keir Starmer vows to stay on. And Boeing’s Kelly Ortberg heads to China chasing a deal. Listen to the day’s top stories . — Hellmuth Tromm Market Snapshot S&P 500 Futures 7,410.75 -0.3% Nasdaq 100 Futures 29,203.00 -0.8% WTI crude oil futures $101.74 +3.7% Market data as of 07:07 AM ET. Data is subject to provider de...
Good morning . Oil keeps rising while tech stocks take a pause. UK Prime Minister Keir Starmer vows to stay on. And Boeing’s Kelly Ortberg heads to China chasing a deal. Listen to the day’s top stories . — Hellmuth Tromm Market Snapshot S&P 500 Futures 7,410.75 -0.3% Nasdaq 100 Futures 29,203.00 -0.8% WTI crude oil futures $101.74 +3.7% Market data as of 07:07 AM ET. Data is subject to provider delays. Oil rose for a third straight day while the shaky US-Iran ceasefire kept traders on edge . Tech stocks took a breather ahead of US inflation data and in the wake of renewed warnings the sector’s rally may have gone too far. In Korea, markets were jolted by a proposal to fund a “ citizen dividend ” from AI. UK bonds tumbled as pressure mounts on Prime Minister Keir Starmer after more than 70 Labour MPs called for him to go. Senior figures, including Home Secretary Shabana Mahmood, are pushing for an exit timeline. Starmer, however, is digging in, telling a cabinet meeting he’s not going anywhere . The White House said Trump will meet Xi Jinping in Beijing on Thursday. Nvidia CEO Jensen Huang was left off the delegation , while executives like Tim Cook and Elon Musk made the cut. Boeing CEO Kelly Ortberg is also expected to join and has hinted at a major deal . One potential flashpoint: the US has approved up to $11 billion in arms sales to Taiwan, drawing criticism from Beijing. Back in the US, the government released another 53 million barrels from its emergency oil reserve to ease gas prices that have surged above $4.50 a gallon. Elsewhere on prices, Trump has delayed plans to ease tariffs on beef imports after pushback from Republican allies and ranchers. Trump had been set to sign executive orders yesterday aimed at lowering costs . The administration is also asking a US trade court to keep its 10% global tariffs in place during an appeal. Bond Market’s Warsh Trade Falls Apart as Oil Fans Inflation Risk Read more Progress at the Fed: Kevin Warsh’s nomination cleare...
Futures fell as oil prices topped $100 and as a South Korean official suggested excess AI profits could be given to citizens. The CPI inflation report is on tap.
Futures fell as oil prices topped $100 and as a South Korean official suggested excess AI profits could be given to citizens. The CPI inflation report is on tap.
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Private credit may have been hit by negative headlines, but inflows are unquestionably strong, says Sanjay Jhamna, Head of Global Credit Trading at JPMorgan. He says the fact that recent AI model releases did not result in a negative market reaction shows that the shock has passed for the software sector. Jhamna joined "The Pulse with Francine Lacqua" at the JPMorgan's Global Markets Conference in...
Private credit may have been hit by negative headlines, but inflows are unquestionably strong, says Sanjay Jhamna, Head of Global Credit Trading at JPMorgan. He says the fact that recent AI model releases did not result in a negative market reaction shows that the shock has passed for the software sector. Jhamna joined "The Pulse with Francine Lacqua" at the JPMorgan's Global Markets Conference in Paris. (Source: Bloomberg)
Galeh Kholis Pambudi/iStock via Getty Images As a long term, value-oriented investor, I don't mind underperforming the market, even if it is for an extended window of time. The most important thing is that, in the long run, I beat the market by a measurable degree. If I can't do that, I may as well just put my money an index fund and spend my time more productively. This mindset that I have is why...
Galeh Kholis Pambudi/iStock via Getty Images As a long term, value-oriented investor, I don't mind underperforming the market, even if it is for an extended window of time. The most important thing is that, in the long run, I beat the market by a measurable degree. If I can't do that, I may as well just put my money an index fund and spend my time more productively. This mindset that I have is why I don't mind the fact that, since I called Crown Holdings ( CCK ) a ‘buy’ back in November of last year, the stock has underperformed the market. Shares are up 6.7%, which means that the firm has trailed the 10.7% rise that the S&P 500 experienced over the same window of time. Some of this underperformance is understandable. Although the company is seeing some nice revenue growth, some profitability metrics have worsened as of late. But others are solid, and the stock seems to be trading at a low price both on an absolute basis and relative to other similar companies. In light of this, I have no problem maintaining it as a ‘buy’ candidate right now. Not ready to throw in the towel As a company that operates plants dedicated to producing metal cans and ends for the beverage, food, and aerosol industries, not to mention as a producer of other packaging related products and solutions like those involving steel, paper, and plastic, Crown Holdings might not seem all that exciting a prospect right now. After all, the company is not some high growth tech play. It never will be. That's fine with me. What matters more is that I view it as a fundamentally attractive firm that is trading on the cheap. And that is precisely what we have here. Author - SEC EDGAR Data The best way to prove this would be to look at the most recent data that management has made available. This is data covering the first quarter of the company's 2026 fiscal year . In the chart above, you can see that revenue for the business came in at $3.26 billion. That happens to be 12.9% above the $2.89 billion that th...
(RTTNews) - The London stock market's benchmark FTSE 100 fell on Tuesday as stocks shed ground amid concerns over fading prospects of a U.S.-Iran peace deal, rising oil prices and political uncertainty in the UK.
(RTTNews) - The London stock market's benchmark FTSE 100 fell on Tuesday as stocks shed ground amid concerns over fading prospects of a U.S.-Iran peace deal, rising oil prices and political uncertainty in the UK.
Traffic in the Strait of Hormuz remains at a standstill, with the US President saying the ceasefire is on "massive life support". Dubravko Lakos, Global Head of Market Strategy at JPMorgan, says inventories have helped to offset to the energy shock so far, but we're now heading towards so-called "operational stress levels" that could potentially force the reopening of the Strait. Lakos joined Bloo...
Traffic in the Strait of Hormuz remains at a standstill, with the US President saying the ceasefire is on "massive life support". Dubravko Lakos, Global Head of Market Strategy at JPMorgan, says inventories have helped to offset to the energy shock so far, but we're now heading towards so-called "operational stress levels" that could potentially force the reopening of the Strait. Lakos joined Bloomberg's Francine Lacqua at JPMorgan's Global Markets Conference in Paris. (Source: Bloomberg)